Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keertana Yalamanchili

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedinformatics|August 16, 2024
Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine LearningSoukaina Amniouel, Keertana Yalamanchili, Sreenidhi Sankararaman, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2025
Metformin's effects beyond ischemia: Evaluating cardioprotection in nonischemic myocardium in a large animal model of coronary and metabolic diseaseKeertana Yalamanchili, Christopher Stone, Kelsey C Muir, et al.
Membranes|May 28, 2022
Understanding the Dynamics of the Transient and Permanent Opening Events of the Mitochondrial Permeability Transition Pore with a Novel Stochastic ModelKeertana Yalamanchili, Nasrin Afzal, Liron Boyman, et al.
Frontiers in Cardiovascular Medicine|June 22, 2026
Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategiesClark Zheng, Kelsey Muir, Himanshu Kaushik, et al.
Vascular Pharmacology|August 23, 2025
Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failureJad Hamze, Christopher Stone, Dwight Douglas Harris, et al.
Asian Cardiovascular & Thoracic Annals|July 3, 2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunctionMeghamsh Kanuparthy, Dwight D Harris, Mark Broadwin, et al.
Journal of Clinical Medicine|September 27, 2025
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular TherapeuticKeertana Yalamanchili, Mark Broadwin, Dwight D Harris, et al.
Bioengineering (Basel, Switzerland)|January 28, 2026
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant ModelsKelsey C Muir, Clark Zheng, Keertana Yalamanchili, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 12, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher Stone, Dwight D Harris, Mark Broadwin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher R Stone, Dwight D Harris, Mark Broadwin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedinformatics|August 16, 2024
Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine LearningSoukaina Amniouel, Keertana Yalamanchili, Sreenidhi Sankararaman, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2025
Metformin's effects beyond ischemia: Evaluating cardioprotection in nonischemic myocardium in a large animal model of coronary and metabolic diseaseKeertana Yalamanchili, Christopher Stone, Kelsey C Muir, et al.
Membranes|May 28, 2022
Understanding the Dynamics of the Transient and Permanent Opening Events of the Mitochondrial Permeability Transition Pore with a Novel Stochastic ModelKeertana Yalamanchili, Nasrin Afzal, Liron Boyman, et al.
Frontiers in Cardiovascular Medicine|June 22, 2026
Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategiesClark Zheng, Kelsey Muir, Himanshu Kaushik, et al.
Vascular Pharmacology|August 23, 2025
Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failureJad Hamze, Christopher Stone, Dwight Douglas Harris, et al.
Asian Cardiovascular & Thoracic Annals|July 3, 2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunctionMeghamsh Kanuparthy, Dwight D Harris, Mark Broadwin, et al.
Journal of Clinical Medicine|September 27, 2025
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular TherapeuticKeertana Yalamanchili, Mark Broadwin, Dwight D Harris, et al.
Bioengineering (Basel, Switzerland)|January 28, 2026
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant ModelsKelsey C Muir, Clark Zheng, Keertana Yalamanchili, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 12, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher Stone, Dwight D Harris, Mark Broadwin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher R Stone, Dwight D Harris, Mark Broadwin, et al.
Pageof 1